Moneycontrol PRO
Open App
fortis healthcare
Jump to
  • IHH Healthcare in discussions with Indian authorities over stalled open offer in Fortis Healthcare Sep 28, 2022 07:30 AM IST

    IHH Healthcare in discussions with Indian authorities over stalled open offer in Fortis Healthcare

    The Supreme Court had last week ordered a forensic audit of the share sale of Fortis Healthcare to IHH Healthcare executed in 2018, in a contempt case filed by Japanese firm Daiichi Sankyo Company Ltd against the former promoters of Fortis, Singh brothers -- Malvinder and Shivinder, and others.

  • EX-promoters of Fortis Healthcare failed to purge themselves of contempt, says SC Sep 23, 2022 08:01 PM IST

    EX-promoters of Fortis Healthcare failed to purge themselves of contempt, says SC

    The former promoters of Fortis Healthcare Ltd were facing a court battle after Daiichi had challenged the Fortis-IHH share deal to recover the Rs 3,600 crore arbitration award.

  • Max, Fortis, Apollo and other big hospital chains have been overcharging patients: CCI investigation Sep 23, 2022 10:28 AM IST

    Max, Fortis, Apollo and other big hospital chains have been overcharging patients: CCI investigation

    The potential penalty by India’s fair trade regulator could be steep. The CCI investigation is the first such action against exorbitant prices of medicines and services fixed by hospitals, which have operated free of regulation so far.

  • Fortis Healthcare shares drop 20% as Supreme Court orders status quo on IHH deal Sep 22, 2022 11:13 AM IST

    Fortis Healthcare shares drop 20% as Supreme Court orders status quo on IHH deal

    The verdict further delays the takeover of the embattled hospital chain Fortis Healthcare by Malaysia’s IHH, which has already been pending for over three years.

  • US court dismisses suit against Fortis Healthcare, others Sep 09, 2022 10:46 PM IST

    US court dismisses suit against Fortis Healthcare, others

    In January this year, Fortis had announced that Envesecure filed a suit against it and various others for alleged "copyright infringement and tortious interference with contracts", seeking damages in excess of USD 6.5 billion.

  • As Centre readies ‘Heal in India’ portal, hospital chains suggest a slew of measures on medical tourism Sep 05, 2022 03:54 PM IST

    As Centre readies ‘Heal in India’ portal, hospital chains suggest a slew of measures on medical tourism

    Large private hospital chains have sought ease in securing visas and suggested that a welcome desk be set up at international airports in a separate lounge where arriving patients can rest

  • Buy Fortis Healthcare; target of Rs 330: Prabhudas Lilladher Aug 10, 2022 06:46 PM IST

    Buy Fortis Healthcare; target of Rs 330: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 330 in its research report dated August 09, 2022.

  • Fortis Health Consolidated June 2022 Net Sales at Rs 1,487.85 crore, up 5.5% Y-o-Y Aug 06, 2022 11:33 AM IST

    Fortis Health Consolidated June 2022 Net Sales at Rs 1,487.85 crore, up 5.5% Y-o-Y

  • Fortis Health Standalone June 2022 Net Sales at Rs 247.15 crore, up 21.44% Y-o-Y Aug 06, 2022 10:55 AM IST

    Fortis Health Standalone June 2022 Net Sales at Rs 247.15 crore, up 21.44% Y-o-Y

  • Fortis Healthcare Q1 PAT may dip 58.3% YoY to Rs 109.8 cr: Prabhudas Lilladher Jul 08, 2022 05:56 PM IST

    Fortis Healthcare Q1 PAT may dip 58.3% YoY to Rs 109.8 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 3 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs 1,452.3 crore, according to Prabhudas Lilladher.

  • Fortis Health Consolidated March 2022 Net Sales at Rs 1,378.10 crore, up 10.03% Y-o-Y May 26, 2022 09:33 AM IST

    Fortis Health Consolidated March 2022 Net Sales at Rs 1,378.10 crore, up 10.03% Y-o-Y

  • Fortis Health Standalone March 2022 Net Sales at Rs 210.26 crore, up 7.93% Y-o-Y May 26, 2022 09:11 AM IST

    Fortis Health Standalone March 2022 Net Sales at Rs 210.26 crore, up 7.93% Y-o-Y

  • Service costs, margins need to be considered before price cap on drugs and devices: Dr BS Ajai Kumar of HealthCare Global Apr 01, 2022 03:00 PM IST

    Service costs, margins need to be considered before price cap on drugs and devices: Dr BS Ajai Kumar of HealthCare Global

    Dr Kumar said patients should look at the bundled service costs and not prices of medicines or devices.

  • Big hospital chains face CCI scrutiny over inflated prices of medicines and medical devices Apr 01, 2022 11:14 AM IST

    Big hospital chains face CCI scrutiny over inflated prices of medicines and medical devices

    Competition Commission of India (CCI) has demanded answers from Max Healthcare, Fortis Healthcare and Apollo Hospitals on how they fix prices of medicines and medical devices. Action could rein in soaring drug prices in India.

  • SC rejects Fortis Healthcare ex-promoter Shivinder Singh's interim bail plea Mar 16, 2022 05:13 PM IST

    SC rejects Fortis Healthcare ex-promoter Shivinder Singh's interim bail plea

    Shivinder Mohan Singh is currently facing charges in a money laundering case related to alleged misappropriation of funds at Religare Finvest Limited (RFL).

  • Hot Stocks | Here is why you should bet on Fortis Healthcare, Ambuja Cements, HCL Technologies in short term Mar 10, 2022 07:25 AM IST

    Hot Stocks | Here is why you should bet on Fortis Healthcare, Ambuja Cements, HCL Technologies in short term

    After a continuous fall in Ambuja Cements, prices have found support near its 200-week exponential moving average and in terms of candle stick counter has formed a Bullish Hammer pattern on the weekly time frame.

  • Top 10 trading ideas by experts amid market volatility, for next 3-4 weeks Feb 14, 2022 08:57 AM IST

    Top 10 trading ideas by experts amid market volatility, for next 3-4 weeks

    Until the decisive breakout is not seen on the Nifty, one should expect a rangebound movement and focus on stock-specific action, Sameet Chavan of Angel One advised

  • Trade Spotlight | What should investors do with Hindalco, Bata India, Fortis Healthcare, Ramco Cements and Titan? Jan 03, 2022 07:25 AM IST

    Trade Spotlight | What should investors do with Hindalco, Bata India, Fortis Healthcare, Ramco Cements and Titan?

    Here's what Rajesh Palviya of Axis Securities, recommends investors should do with these stocks when the market resumes trading today.

  • Hot Stocks | Here's why you should buy Fortis Healthcare, Escorts, Metropolis Healthcare for short term Nov 17, 2021 07:54 AM IST

    Hot Stocks | Here's why you should buy Fortis Healthcare, Escorts, Metropolis Healthcare for short term

    Traders should keep stock specific action on radar, as volatility is likely to grip markets in the coming week once again.

  • Siphoning of Religare Finvest Ltd funds: SC to hear bail plea of Shivinder Mohan on November 11 Nov 09, 2021 08:23 PM IST

    Siphoning of Religare Finvest Ltd funds: SC to hear bail plea of Shivinder Mohan on November 11

    The top court, which wanted to remand the case to the Delhi High Court for re-adjudication on October 25, kept it for hearing before itself after the Economic Offence Wing of Delhi Police referred to the gravity of the offence.

  • Before Zee, these companies’ shareholders ousted promoters Sep 15, 2021 10:15 AM IST

    Before Zee, these companies’ shareholders ousted promoters

    Shareholders of Zee have called in for a special meeting seeking removal of MD Punit Goenka along with two other directors from the board. This isn’t the first time when shareholders of a certain company have shown exit door to the promoters. Watch the video to find out about such companies.

  • Fortis Health Consolidated June 2021 Net Sales at Rs 1,410.31 crore, up 132.74% Y-o-Y Aug 30, 2021 07:44 PM IST

    Fortis Health Consolidated June 2021 Net Sales at Rs 1,410.31 crore, up 132.74% Y-o-Y

  • Fortis Healthcare share price hits 52-week high; Goldman Sachs maintains ‘buy’ Aug 17, 2021 09:56 AM IST

    Fortis Healthcare share price hits 52-week high; Goldman Sachs maintains ‘buy’

    The share price has risen more than 90 percent in the last year

  • IPO radar | Is KIMS a dark horse in the making? Jun 16, 2021 10:39 AM IST

    IPO radar | Is KIMS a dark horse in the making?

    The growth strategy at KIMS is based on volume play driven by hinterland opportunities

  • HDFC Securities sees 15% upside in Fortis Healthcare despite cap on vaccination charge, here's why Jun 10, 2021 10:40 AM IST

    HDFC Securities sees 15% upside in Fortis Healthcare despite cap on vaccination charge, here's why

    The brokerage firm has a buy on the stock on dips around Rs 199-200 with a target price of Rs 271, an upside of 15 percent from the current level.

Sections
ISO 27001 - BSI Assurance Mark